Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_assertion type Assertion NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_head.
- NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_assertion wasGeneratedBy ECO_0000203 NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_provenance.
- NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_assertion wasDerivedFrom befree-20150227 NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_provenance.
- NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_assertion SIO_000772 24746896 NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_provenance.
- NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_assertion evidence source_evidence_literature NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_provenance.
- NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_assertion description "[In conclusion the frequency of CSF3R mutations is highly prevalent among AML patients secondary to SCN compared to de novo AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332250.RABDEXHvShSgtSWETQ4wMJ0BlyssxtChVTvztOyTmicGo130_provenance.